157 related articles for article (PubMed ID: 8568546)
21. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
22. Comparative in vitro activity of tobramycin and gentamicin on three different media.
Sandven P; Lassen J; Solberg O; Evandt O
Chemotherapy; 1980; 26(5):354-60. PubMed ID: 7389429
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
Manoharan A; Lalitha MK; Jesudason MV
Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
[TBL] [Abstract][Full Text] [Related]
24. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.
Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA
Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751
[TBL] [Abstract][Full Text] [Related]
25. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
26. Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.
den Hollander JG; Mouton JW; van Goor MP; Vleggaar FP; Verbrugh HA
Antimicrob Agents Chemother; 1996 Mar; 40(3):784-6. PubMed ID: 8851612
[TBL] [Abstract][Full Text] [Related]
27. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
28. [Tobramycin--clinical pharmacology and chemotherapy].
Periti P
J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
[TBL] [Abstract][Full Text] [Related]
29. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
Skalova R; Hajsig D; Babić I; Mostovac D
Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
[No Abstract] [Full Text] [Related]
30. An outbreak of infection caused by a gentamicin-resistant Staphylococcus aureus.
Bint AJ; George RH; Healing DE; Wise R; Davies M
J Clin Pathol; 1977 Feb; 30(2):165-7. PubMed ID: 845264
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
Juvin ME; Drugeon HB; Caillon J; Pirault JL
Pathol Biol (Paris); 1987 May; 35(5):461-5. PubMed ID: 3302848
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
33. Laboratory findings of tobramycin and their relation to clinical response.
McAllister TA; Tait SC
J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
[TBL] [Abstract][Full Text] [Related]
36. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
Duroś H; Nowakowska K
Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
[TBL] [Abstract][Full Text] [Related]
37. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
[TBL] [Abstract][Full Text] [Related]
38. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model.
Zhu ZY; Li RC
J Antimicrob Chemother; 1998 Jul; 42(1):61-5. PubMed ID: 9700529
[TBL] [Abstract][Full Text] [Related]
39. Bactericidal kinetics and postantibiotic effect of sparfloxacin against selected species of respiratory pathogens.
Speciale A; Blandino G; Nicolosi VM; Siracusa V; Caccamo F
J Chemother; 1995 Dec; 7(6):530-4. PubMed ID: 8667038
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model.
Huang V; Rybak MJ
Antimicrob Agents Chemother; 2005 Jan; 49(1):302-8. PubMed ID: 15616309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
